PolyPeptide Group AG
PPGN | SW
Overview
Corporate Details
- ISIN(s):
- CH1110760852
- LEI:
- 5067007JCKTPOX4G9758
- Country:
- Switzerland
- Address:
- Neuhofstrasse 24, 6340 Baar
- Website:
- https://www.polypeptide.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PolyPeptide Group AG is a global Contract Development & Manufacturing Organization (CDMO) specializing in peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). The company provides comprehensive services to pharmaceutical and biotech partners, supporting the development and manufacturing of both proprietary and generic products. PolyPeptide assists clients throughout the product lifecycle, from initial development to regulatory approval and commercial launch. A key focus is on innovation in large-scale production and sustainable manufacturing processes, such as green peptide chemistry, to enhance process performance while minimizing environmental impact.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for PolyPeptide Group AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 06:55 |
Earnings Release
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian …
|
English | 31.7 KB | |
| 2025-08-12 02:00 |
Earnings Release
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian …
|
English | 28.4 KB | |
| 2025-08-12 02:00 |
Earnings Release
PolyPeptide wächst im ersten Halbjahr 2025 um 24%, mit einer erfolgreichen Anla…
|
German | 32.6 KB | |
| 2025-05-23 07:00 |
Capital/Financing Update
PolyPeptide announces expansion of existing credit facilities
|
English | 7.8 KB | |
| 2025-05-23 02:00 |
Capital/Financing Update
PolyPeptide announces expansion of existing credit facilities
|
English | 6.0 KB | |
| 2025-05-23 02:00 |
Capital/Financing Update
PolyPeptide gibt Ausweitung des bestehenden Kreditrahmens bekannt
|
German | 7.0 KB | |
| 2025-04-09 18:34 |
Post-Annual General Meeting Information
PolyPeptide announces results of the annual General Meeting 2025
|
English | 9.3 KB | |
| 2025-03-19 07:00 |
Pre-Annual General Meeting Information
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | |
| 2025-03-18 07:00 |
Pre-Annual General Meeting Information
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | |
| 2025-03-18 01:00 |
Pre-Annual General Meeting Information
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 7.1 KB | |
| 2025-03-18 01:00 |
Pre-Annual General Meeting Information
PolyPeptide publiziert Einladung zur ordentlichen Generalversammlung 2025
|
German | 8.0 KB | |
| 2025-03-12 06:55 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 32.1 KB | |
| 2025-03-11 06:55 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 32.1 KB | |
| 2025-03-11 01:00 |
Earnings Release
PolyPeptide with substantial improvements in profitability and cash flow, posit…
|
English | 28.2 KB | |
| 2025-03-11 01:00 |
Earnings Release
PolyPeptide mit substantiellen Verbesserungen bei Profitabilität und Cashflow, …
|
German | 32.0 KB |
Automate Your Workflow. Get a real-time feed of all PolyPeptide Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PolyPeptide Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 35,000.00 CHF |
| 2023-11-10 | N/A | Executive member | Buy | None | 51,250.00 CHF |
| 2023-10-11 | N/A | Executive member | Buy | None | 2,876,348.62 CHF |
| 2023-10-10 | N/A | Executive member | Buy | None | 371,202.96 CHF |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
